Barclays Maintains an 'Overweight' on Sequenom (SQNM); Dennis Lo's Data Reads Out As Expected
Tweet Send to a Friend
Barclays maintains an 'Overweight' on Sequenom (NASDAQ: SQNM), PT $9.
Barclays analyst says, "Dennis Lo's much awaited publication on sequencing ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Barclays analyst says, "Dennis Lo's much awaited publication on sequencing ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
